Other safety alerts
|
| |
| Canada: Unauthorized health products seized from Tokyo Beauty & Health Care in Richmond, B.C., may pose serious health risks |
| |
Health Canada announces that it has seized several health products, including eye drops, an eyewash and an acne gel, from Tokyo Beauty & Health Care in Richmond, British Columbia (#120, 8191 Westminster Highway), because they are unauthorized and may pose serious health risks. The affected products are:
- Dalacin T Gel 1% (Anti-bacterial gel for acne): Labelled (in Japanese) to contain clindamycin
- Kobayashi Aibon/Eyebon Eyewash ALd (dark green) (Eyewash): Labelled (in Japanese) to contain aminocaproic acid
- Kobayashi Aibon/Eyebon Eyewash Medicala (black) (Eyewash): Labelled (in Japanese) to contain aminocaproic acid
- Kobayashi Aibon/Eyebon Eyewash Mild (light green) (Eyewash): Labelled (in Japanese) to contain aminocaproic acid
- Santen Sante Beauteye Contact (Eye drops): Labelled (in Japanese) to contain neostigmine methylsulfate
- Santen Sante FX Neo (silver package) (Eye drops): Labelled (in English) to contain neostigmine methylsulfate and aminocaproic acid
- Santen Sante FX Neo (blue package) (Eye drops): Labelled (in Japanese) to contain neostigmine methylsulfate and aminocaproic acid
- Santen Sante FX Vplus (gold package) (Eye drops): Labelled (in English) to contain neostigmine methylsulfate and aminocaproic acid
- Santen Sante FX Vplus (red package) (Eye drops): Labelled (in Japanese) to contain neostigmine methylsulfate and aminocaproic acid
- Santen Sante PC (Eye drops): Labelled (in Japanese) to contain neostigmine methylsulfate
According to the product labels, the products contain prescription drugs. Prescription drugs should be taken only under the advice and supervision of a health care professional because of the risk of interactions with other medications and side effects. Prescription drugs can only be legally sold via a prescription.
Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, effectiveness and quality and may pose serious health risks. They may contain ingredients, additives or contaminated ingredients not listed on the label. In addition, they may lack the active ingredients Canadians would expect them to contain to help maintain and improve their health or they may contain ingredients that could interact with other medications and foods. For all of these reasons, unauthorized health products could cause serious health effects.
Some of the unauthorized health products are packaged and labelled in Japanese characters. As a result, information about ingredients, usage, dosage and side effects may not be understood by all consumers.
Please refer to the following website in Health Canada for details:
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../75279a-eng.php
In Hong Kong, Dalacin T Topical Gel 1% (HK-37199) is a pharmaceutical product registered by Pfizer Corporation Hong Kong Limited, and is a prescription-only medicine. The packaging of the product Dalacin T Gel 1% in Canada is different from the registered packaging in Hong Kong.
The other above products in Canada are not registered pharmaceutical products in Hong Kong.
Related news was previously issued by Health Canada, and was posted on the Drug Office website since 29 Aug 2017, with the latest update posted on 25 Jul 2019.
Ends/Thursday, Apr 1, 2021
Issued at HKT 16:00
|
| |
|
